On the accession of the Republic of Kazakhstan to the Convention on Psychotropic Substances

Home / RLA / On the accession of the Republic of Kazakhstan to the Convention on Psychotropic Substances

Law of the Republic of Kazakhstan dated June 29, 1998 No. 249

The Republic of Kazakhstan should accede to the Convention on Psychotropic Substances, adopted in Vienna on February 21, 1971.

President of the Republic of Kazakhstan

application

Convention on Psychotropic Substances*

(the text is unofficial) The preamble The Parties, taking care of the health and well-being of mankind, noting with concern the existence of public health and social problems resulting from the abuse of certain psychotropic substances, determined to prevent and combat the abuse of such substances and the illicit trafficking it generates, considering, That strict measures are needed to limit the use of such substances for legitimate purposes, Recognizing that the use of psychotropic substances for medical and scientific purposes is necessary and that their availability for such purposes should not be unduly limited, Considering that in order for measures against the abuse of such substances to be effective, they must be coordinated and universal, recognizing the competence of The United Nations in the field of psychotropic substances control and desiring, In order for the international bodies concerned to be within the framework of this Organization, recognizing that an international convention is necessary to achieve these goals, have agreed as follows:

Article 1. Use of terms Unless explicitly stated otherwise or the context requires otherwise, the following terms used in this Convention have the following meanings: (a) "Council" means the Economic and Social Council of the Organization Of the United Nations. (b) "Commission" means the Commission on Narcotic Drugs Of the Economic and Social Council. (c) "Committee" means the International Narcotics Control Board provided for in the Single Convention on Narcotic Drugs of 1961. (d) "Secretary-General" means the Secretary-General of the Organization Of the United Nations. (e) "Psychotropic substance" means any substance, natural or synthetic, or any natural material included in Schedule I, II, III or IV. (f) "Drug" means: i) any solution or mixture in any physical condition containing one or more psychotropic substances, or ii) one or more psychotropic substances in therapeutic doses. (g) "List I", "List II", "List III" and "List IV" mean, respectively, the numbered lists of psychotropic substances annexed to this Convention, which may be amended in accordance with article 2. (h) "Export" and "Import" mean, each in an appropriate context, the physical transfer of a psychotropic substance from one State to another State. (i) "Manufacture" means all processes by which psychotropic substances can be obtained, and includes both the refining and conversion of some psychotropic substances into other psychotropic substances. This term also includes the manufacture of drugs other than prescription drugs in pharmacies. (j) "Illicit trafficking" means the manufacture of psychotropic substances or their sale or acquisition in violation of the provisions of this Convention. (k) "Area" means any part of a State which, in accordance with article 28, is considered for the purposes of this Convention. as a separate unit. (l) "Premises" means buildings or parts of buildings, including the land plot serving them.

Article 2. Scope of control of substances 1. If any Party or the World Health Organization has information about any substance not yet under international control that, in its opinion, may require the inclusion of this substance in one of the Lists of this Convention, it shall notify the Secretary-General and provide him with information in support of this notification. The above procedure shall also apply if a Party or the World Health Organization has information on the basis of which a substance should be transferred from one List of this Convention to another or a substance should be removed from these Lists. 2. The Secretary-General shall transmit such notification, as well as any information which, in his opinion, is relevant to the matter, to the Parties, the Commission and, when such notification is received from any Party, to the World Health Organization. 3. If the information sent with such notification indicates that the substance is suitable for inclusion in Schedule I or Schedule II of this Convention in accordance with paragraph 4 of this Article, the Parties shall examine, in the light of all information at their disposal, the possibility of temporarily applying to the substance all control measures applicable to substances included in List I or List II, respectively. 4. If the World Health Organization considers that (a) this substance has the ability to: i) 1) cause a state of dependence and 2) have a stimulating or depressive effect on the central nervous system, causing hallucinations or disorders of motor function, or thinking, or behavior, or perception, or mood; or (ii) lead to similar abuse and similar harmful effects as any substance listed in Schedule I, II, III or IV; and (b) there is sufficient evidence that there is abuse of the substance in question or there is a possibility of such abuse that poses or may pose a public health problem and a social problem, giving grounds for the application of international control measures to this substance. The World Health Organization shall communicate to the Commission an assessment of the substance, including an assessment of the extent or likelihood of abuse, the severity of the health and social problem, and the usefulness of the substance in therapeutic practice, as well as recommendations, if any, on control measures that would be appropriate in the light of its assessment. 5 The Commission, taking into account the above-mentioned communication from the World Health Organization, whose assessments in medical and scientific matters are decisive, and taking into account the economic, social, legal, administrative and other factors that, in its opinion, are relevant to this issue, may include this substance in Schedule I, II, III or IV. The Commission may request additional information from the World Health Organization or other relevant sources. 6. If any notification under paragraph 1 concerns a substance already included in one of the Lists, the World Health Organization shall communicate to the Commission its new opinion, any new assessment of the substance that it may make in accordance with paragraph 4, as well as any new recommendations on control measures that it deems appropriate. appropriate in the light of this assessment. The Commission, taking into account the communication from the World Health Organization in accordance with paragraph 5 and taking into account the factors referred to in that paragraph, may decide to transfer the substance from one List to another or to remove it from the Lists. 7. Any decision of the Commission taken pursuant to this article shall be communicated by the Secretary-General to all Member States of the United Nations, the Parties to this Convention that are not members of the United Nations, the World Health Organization and the Committee. Such a decision shall enter into full force for each Party 180 days after the date of such notification, with the exception of any Party that, within that period, has notified the Secretary-General in writing with respect to the decision to add a substance to one of their Lists that, due to exceptional circumstances, In these circumstances, it is not in a position to give effect to all the provisions of this Convention applicable to substances included in this List in relation to this substance. Such notification shall indicate the reasons for this exceptional measure. Regardless of its notification, each The Party shall apply, at a minimum, the control measures listed below: a) The Party, having sent such notification regarding the non-

About

The control of a substance added to Schedule I shall take into account, to the extent possible, the special control measures listed in Article 7 and in respect of that substance.: (i) Requires licenses for manufacture, trade and distribution, as provided for in Article 8 for substances included in Schedule II; (ii) requires a doctor's prescription for supply or release, as provided for in Article 9 for substances included in Schedule II; (iii) Fulfills the export and import obligations provided for in Article 12, with the exception of obligations with respect to the other Party that has notified the substance; (iv) fulfills the obligations provided for in Article 13 for substances included in Schedule II with respect to the prohibition and restriction of exports and imports; (v) submits statistical reports to the Committee in accordance with subparagraph (a) of paragraph 4 of article 16; and vi) take measures in accordance with article 22 to suppress actions contrary to laws or regulations adopted in fulfillment of the aforementioned obligations. (b) A Party, by sending such notification regarding a previously uncontrolled substance added to Schedule II, in respect of that substance: (i) Requires licenses for manufacture, trade and distribution in accordance with Article 8; (ii) requires a doctor's prescription for supply or release in accordance with Article 9; (iii) Fulfills the export and import obligations provided for in Article 12, with the exception of obligations with respect to the other Party that has notified the substance; (iv) fulfills the obligations set out in Article 13 with respect to the prohibition and restriction of exports and imports; (v) submits statistical reports to the Committee in accordance with the sub-paragraphs "a", "c" and "d" of paragraph 4 of article 16; (vi) Take measures in accordance with article 22 to suppress actions contrary to laws or regulations adopted in pursuance of the aforementioned obligations. (c) A Party, by sending such notification regarding a previously uncontrolled substance added to Schedule III, in respect of that substance: (i) Requires licenses for manufacture, trade and distribution in accordance with Article 8; (ii) requires a doctor's prescription for supply or release in accordance with Article 9; (iii) fulfills the export obligations provided for in Article 12, with the exception of obligations with respect to the other Party that has given such notification regarding the substance; (iv) fulfills the obligations set out in Article 13 with respect to the prohibition and restriction of exports and imports; and (v) takes measures in accordance with Article 22 to suppress acts that contrary to laws or regulations adopted in fulfillment of the aforementioned obligations. (d) A Party, by sending such notification regarding a previously uncontrolled substance added to Schedule IV, in respect of that substance: (i) Requires licenses for manufacture, trade and distribution in accordance with Article 8; (ii) fulfills the obligations set out in article 13 with respect to the prohibition and restriction of exports and imports; and (iii) takes measures in accordance with article 22 to suppress acts contrary to laws or regulations adopted in pursuance of the aforementioned obligations.

f) A Party, having sent such a notification regarding any substance transferred to a List providing for stricter control measures and obligations, shall apply, at a minimum, all the provisions of this Convention. Conventions applicable to the list from which it was moved. 8. (a) Decisions of the Commission taken in accordance with this article shall be subject to review by the Council at the request of any Party sent within 180 days from the date of receipt of notification of the adoption of this decision. The request for review is sent to the Secretary-General along with all relevant information on which the request for review is based. (b) The Secretary-General shall send copies of the said request for review and relevant information to the Commission, the World Health Organization and all Parties, inviting them to submit their comments within ninety days. All comments received are submitted to the Council for consideration. (c) The Council may confirm, amend or reverse the Commission's decision. Notification of the Council's decision shall be sent to all Member States of the United Nations, to the States Parties to this Convention that are not members of the United Nations, to the Commission, to the World Health Organization and to the Committee. d) During the period prior to the said review, the initial decision The Commission, subject to paragraph 7, remains in force. 9. The Parties shall do their best to apply such surveillance measures as may be practicable to substances not covered by this Convention, but which may be used for the illicit manufacture of psychotropic substances.

Article 3. Special provisions concerning drug control 1. With the exception of the cases provided for in the following paragraphs of this article, the same control measures are applied to the drug as to the psychotropic substance contained in it; if the drug contains not one but several such substances, it is subject to the measures applied to that substance. of the substances that are subject to the most stringent control measures. 2. If any drug containing any psychotropic substance, with the exception of any substance included in Schedule I, has a composition such that the risk of abuse is absent or negligible and that this substance cannot be extracted by readily available methods in an amount at which abuse is possible, so If the drug in question does not pose a public health or social problem, such a drug may be withdrawn from certain control measures provided for in this Convention in accordance with paragraph 3.3. If a Party concludes on the basis of the preceding paragraph with respect to a drug, it may decide to withdraw that drug in its country or in one of its regions from any one or all of the control measures provided for in this Convention. The Convention, with the exception of the provisions of: (a) Article 8 (licenses) with regard to manufacture; (b) Article 11 (registration records) with regard to drugs withdrawn from control; (c) Article 13 (prohibition and restriction of exports and imports); (d) Article 15 (inspection) with regard to manufacture; (e) Article 16 (reports submitted by the Parties) with regard to drugs seized from control; and (f) Article 22 (penal provisions), to the extent necessary to suppress acts contrary to the laws or resolutions adopted in fulfillment of the above-mentioned obligations. The Party shall notify the Secretary-General of any such decision, of the name and composition of the drug withdrawn from control, and of the control measures from which it has been withdrawn. The Secretary General transmits This is a notification to other Parties, the World Health Organization and the Committee. 4. If a Party or the World Health Organization has information about any drug withdrawn from control pursuant to paragraph 3, which, in its opinion, may require a complete or partial cessation of seizures, it shall notify the Secretary-General accordingly. The Secretary and provides him with information in support of this notification. The Secretary-General shall forward such notification and any information he considers relevant to the matter to the Parties, the Commission and, when such notification is received from any Party, the World Health Organization. The World Health Organization reports The Commission evaluates this drug on the issues referred to in paragraph 2, together with a recommendation on control measures, if necessary, from which the withdrawal of this drug should cease. The Commission, taking into account the above-mentioned message from the World Health Organization, whose assessments in medical and scientific matters are decisive, and taking into account the economic, social, legal, administrative and other factors that, in its opinion, are relevant to this issue, may decide to discontinue the withdrawal of this drug from the scope of anyeither one or all control measures. The Secretary-General shall notify all Member States of the Organization of any decision of the Commission taken pursuant to this paragraph. Of the United Nations, the non-member Parties to this Convention The United Nations, the World Health Organization and the Committee. All Parties shall take measures to terminate the exemption from the action of the measure or control measures under consideration within 180 days from the date of notification by the Secretary General.

Article 4. Other special provisions concerning the scope of control With respect to psychotropic substances other than those included in Schedule I, the Parties may authorize: a) persons traveling from one country to another should have small quantities of drugs with them for their personal use; however, each Party has the right to verify that these drugs were obtained legally; (b) The use of such substances in industry for the manufacture of non-psychotropic substances or products, applying to them the control measures provided for in this Convention, until such time as these psychotropic substances acquire a condition in which there is practically no abuse of these substances or their extraction; and (c) the use of such substances - in compliance with The control measures provided for in this Convention are for trapping animals by persons who have special permission from the competent authorities to use such substances for this purpose.

Article 5. Limitation of use for medical and scientific purposes 1. Each Party restricts the use of substances included in Schedule I, as provided for in Article 7.2. Each Party, with the exception of the cases provided for in Article 4, shall restrict, by such measures as it deems appropriate, the manufacture, export, import, distribution and storage, use of substances included in Schedules II, III and IV, as well as trade and possession of them for medical and scientific purposese 5. Limitation of use for medical and scientific purposes 1. Each Party restricts the use of substances included in Schedule I, as provided for in Article 7.2. Each Party, with the exception of the cases provided for in Article 4, shall restrict, by such measures as it deems appropriate, the manufacture, export, import, distribution and storage, use of substances included in Schedules II, III and IV, as well as trade and possession of them for medical and scientific purposes. 3. It is advisable that the Parties dt is advisable that the Parties do not allow the possession of substances included in Schedules II, III and IV, except on a legal basis.

Article 6. Special Administration It is desirable that, for the purpose of applying the provisions of this Convention, each Party establish and maintain a special administration that may be the same as, and this will be an advantage to, the special administration established pursuant to the provisions of the conventions on narcotic drugs, or may work in close cooperation with it.

Article 7. Special provisions concerning substances included in Schedule I With respect to substances included in Schedule I, the Parties: a) prohibit all their use, except for use for scientific and very limited medical purposes by duly authorized persons in medical or scientific research institutions directly under the control of their Governments, or with a special permit issued by them; (b) Require that the manufacture, distribution, trade and possession of these substances be carried out under special licenses or permits obtained in advance; (c) Ensure close supervision of the activities and actions referred to in paragraphs (a) and (b); (d) Limit the amount of the substance issued to a duly authorized person; the amount necessary for his permitted purpose; (e) Require persons performing medical or scientific functions to keep records of the purchase of these substances, with a detailed description of their use; such records shall be maintained for at least two years after the last entry on the use of such substances; and (f) Prohibit exports and imports, except in cases where both the exporter and importer are competent authorities or institutions of the exporting and importing country or area, respectively, or other persons or enterprises having a special perand (f) Prohibit exports and imports, except in cases where both the exporter and importer are competent authorities or institutions of the exporting and importing country or area, respectively, or other persons or enterprises having a special permit issued by the competent authorities of their country or area for this purpose. The provisions of paragraph 1 of Article 12 on the granting of permits for the export and import of substances included in Schedule II also apply to substances included in Schedule I.

Article 8. Licenses 1. The Parties require that the manufacture, distribution, and trade of substances included in Schedules II, III, and IV (including export and import trade) be carried out under licenses or other similar control measures. 2. Sides: (a) Exercise control over all duly authorized persons and enterprises that are engaged in or associated with the manufacture or distribution of the substances referred to in paragraph 1, as well as trade in them (including export and import trade); (b) Monitor, by means of licenses or other similar control measures, enterprises and premises in which such manufacture or distribution, as well as such trade, may take place; and (c) ensure that security measures are taken with respect to such enterprises and premises in order to prevent theft or other leakage of stocks. 3. The provisions of paragraphs 1 and 2 of this article concerning licenses or other similar control measures may not apply to persons duly authorized to perform medical and scientific functions when they perform these functions. 4. The Parties shall require that all persons who obtain licenses in accordance with this Convention or who obtain other permits in accordance wThe Parties shall require that all persons who obtain licenses in accordance with this Contion or who obtain other permits in accordance with paragraph 1 of this article or paragraph (b) of Article 7 possess the appropriate qualifications necessary for the effective and accurate implementation of the provisions of such laws and regulations adopted pursuant to this Convention.

Article 9 Prescriptions 1. The Parties require that substances included in Schedules II, III and IV be supplied or dispensed for use by individuals only by prescription, except in cases where individuals may lawfully receive, use, dispense or prescribe such substances in the performance of their duly authorized duties. medical or scientific functions. 2. The Parties The Parties shall take measures to ensure that prescriptions for substances included in Schedules II, III and IV are issued in accordance with accepted medical practice and are subject to such regulations, in particular regarding the number of times they may be reused and their duration of validity, which will be a means of protecting public health and well-being. 3. Notwithstanding paragraph 1, a Party may, if, in its opinion, local circumstances so require, and under such conditions as it may sign, including the maintenance of registration recordsNotwithstanding paragraph 1, a Party may, if, in its opinion, local circumstances so require, and under such conditions as it may sign, including the maintenance ofegistration records, authorize licensed pharmacists or other licensed retail distributors designated by the authorities responsible for public health in its country or part of it. its countries, to supply, at their discretion and without a prescription, for use in exceptional cases by individuals for medical purposes, small amounts of substances included in Schedules III and IV, within the limits of, which are determined by the Parties.

Article 10. Warning labels on packages and advertisements 1. Each Party, taking into account the relevant decisions or recommendations of the World Health Organization, requires that labels, whenever possible and in any case on the cover sheet of retail packages containing psychotropic substances, contain such indications regarding use, including warnings and warnings, which, in its opinion, are necessary for the safety of those who uses these substances. 2. Each Party, taking due account of its constitutional provisions, prohibits the advertising of such substances to the public.

Article 11. Registration records 1. The Parties shall require that, in respect of substances included in Schedule I, manufacturers and all other persons authorized under Article 7 to trade and distribute these substances, keep registration records in accordance with the procedure established by each Party, providing detailed information on the quantities of substances manufactured, on the quantities of stocks of these substances. substances, and for each case of receipt and delivery of such substances - detailed information about the quantity, date, supplier and recipient. 2. The Parties require that, for substances included in Schedules II and III, manufacturers, wholesalers, exporters and importers keep registration records in accordance with the procedure established by each Party, providing detailed information on the quantities of substances manufactured, and for each case of receipt and issuance of such substances, detailed information on the quantity, date, supplier and the recipient. 3. The Parties require that, in respect of substances included in Schedule II, retail distributors, hospital and medical-preventive institutions, as well as scientific research institutions, keep registration records in accordance with the procedure established by each Party, providing detailed information on the quantity, date, supplier and recipient for each case of receipt and issuance of such substances. 4. The Parties shall ensure, through appropriate methods and taking into account professional and trade practices in their countries, that information related to the receipt and distribution of Schedule III substances by retail distributors, hospital and medical treatment and research institutions is easily accessible. 5. The Parties require that, for substances included in Schedule IV, manufacturers, exporters and importers keep registration records in accordance with the procedure established by each Party, indicating the quantities of substances manufactured, exported and imported. 6. The Parties require manufacturers of drugs withdrawn from control in accordance with paragraph 3 of Article 3 to keep registration records regarding the amount of each psychotropic substance used in the manufacture of the drug withdrawn from control, as well as regarding the nature, total quantity and initial issue of the drug withdrawn from control, made from the above substance.. 7. The Parties shall ensure that the registration records and information referred to in this article, which are necessary for the purposes of reporting under Article 16, are maintained for at least two years.

Article 12. Provisions relating to international trade 1. (a) Each Party authorizing the export or import of substances included in Schedule I or II shall require, on a form to be determined by the Commission, a separate export or import permit to be obtained for each such individual export or import transaction, regardless of whether it concerns one or several substances. (b) Such authorization shall indicate the international unregistered name or, in the absence of such name, the designation of the substance in the relevant List, the quantity intended for export or in the relevant List, the quantity intended for export or import, the pharmaceutical form, the name and address of the exporter and importer, as well as the period during which export or import can be performed. If this substance is exported or imported as a preparation, it is also necessary to indicate the name of this preparation, if any. The export permit also indicates the number of the import permit, the date of its issuance and the name of the authority that issued the permit. (c) Before issuing an export permit, the Parties shall require the submission of an import permit issued by the competent authorities of the importing country or area certifying that the import of the substance or substances specified therein is permitted; Such authorization shall be submitted by the person or enterprise applying for an export permit. (d) Each exported consignment of substances must be accompanied by a copy of the export permit, and the Government that issued the export permit shall send a copy of the permit to the Government of the importing country or area. f) After the import has been made, the Government of the importing country or area returns to the Government of the exporting country or area the specified export permit with a mark certifying the actual imported quantity. 2. (a) The Parties shall require that, in respect of each case of export of substances included in Schedule III, exporters draw up a declaration in triplicate on a form prescribed by the Commission containing the following information: (i) The name and address of the exporter and importer; (ii) the international unregistered name of the substance or, in the absence of such a name, the designation of the substance in the relevant List; (iii) The quantity of the substance and the pharmaceutical form in which the substance is exported, and, if exported as a preparation, the name of the preparation, if any; and (iv) the date of shipment. (b) The exporters shall submit two copies of the said declaration to the competent authorities of their country or area. They send the third copy with their cargo. (c) The Party from whose territory any Schedule III substance has been exported shall, as soon as possible, but not later than ninety days after the date of dispatch, send by registered mail to the competent authorities of the importing country or area one copy of the declaration received from the exporter, requesting confirmation of its receipt. (d) The Parties may require that, upon receipt of the goods in question, the importer send to the competent authorities of his country or area a duly certified copy of the declaration attached to the goods, indicating the quantity received and the date of receipt. 3. The following additional provisions apply to substances included in Schedules I and II: (a) The Parties shall exercise the same supervision and control in free ports and zones as in other parts of their territories, provided, however, that they may apply stricter measures. b) The export of goods to the address of the mailbox or bank to the account of a person other than specified in this export permit is prohibited. (c) The export of goods with substances included in Schedule I to assigned Customs warehouses is prohibited. The export of goods containing substances included in Schedule II to an assigned customs warehouse is prohibited, except in cases where the Government of the importing country indicates in the import permit submitted by the person or institution applying for export authorization that it authorizes the import in order to place the imported goods in an assigned customs warehouse. In this case, the export permit indicates that the cargo is being exported for this purpose. Any delivery of cargo from an assigned customs warehouse requires the permission of the authorities in charge of this customs warehouse, and in the case of sending cargo abroad, its delivery is considered. as a new export in the context of this Convention. (d) Goods imported into or exported from the territory of a Party without an accompanying export permit are subject to detention by the competent authorities. (e) A Party shall not permit the transit through its territory of any substances destined for another country, regardless of whether or not the cargo containing these substances has been removed from the vehicle on which it was transported, except in cases where the competent authorities of such The Parties must present a copy of the export permit for the cargo. (f) The competent authorities of any country or area through which the transit of a cargo with substances is permitted shall take all necessary measures to prevent the cargo from following a destination other than that indicated in the accompanying copy of the export permit, except in cases where such a change of route is made with the permission of the Government. the country or area through which the cargo is being transited. The Government of the country or area through which the transit is carried out treats any request for a change in the route of the cargo as if such a change were an export from the country or area through which the transit is carried out to the country or area of the new destination. If such a change of route is permitted, the provisions of subparagraph (e) of paragraph 1 of this article shall also apply in the relations between the country or area through which the transit is carried out and the country or area from which the cargo was originally exported. (g) No cargo with substances in transit or located in an assigned Customs warehouse may be exposed to any process that would change the nature of the substance in question. The packaging cannot be changed without the permission of the competent authorities. (h) The provisions of subparagraphs (e) to (g) of this paragraph concerning the passage of substances through the territory of a Party shall not apply in cases where the cargo is transported by aircraft, provided that the aircraft flies over the country or area through which the transit is carried out without landing. If the aircraft lands in any such country or any such area, these provisions shall apply as appropriate. (i) The provisions of this paragraph are without prejudice to the provisions of any international agreements limiting the control that any Party may exercise over such substances in transit.

Article 13. Prohibition and restriction of exports and imports 1. A Party may notify all other Parties through the Secretary General The Secretary-General that it prohibits the importation into its country or into one of its areas of one or more substances included in Schedule II, III or IV, the names of which are indicated in its notification. Such notification shall indicate the name of the substance under which it is listed in Schedule II, III or IV. 2. Upon receipt by a Party of a notification of a ban in accordance with paragraph 1, it shall take measures to ensure that none of the substances specified in such notification is exported to the country or to one of the areas of the Party that sent the notification. 3. Notwithstanding the provisions of the preceding paragraphs, a Party that has made a notification in accordance with paragraph 1 may, by issuing special import licenses in each case, authorize the import of a certain amount of the substances mentioned or preparations containing such substances. The authorities of the importing country issuing such licenses shall send two copies of this special import license, indicating in them the name and address of the importer and exporter, to the competent authorities of the exporting country or area, which, upon receipt, may authorize the exporter to ship the cargo. One copy of this special import license, duly certified by the competent authority of the exporting country or exporting area, is attached to the shipment.

Article 14. Special provisions concerning the transportation of psychotropic substances in first-aid kits on ships, airplanes or other types of public transport operating on international lines 1. The carriage on ships, aircraft or other forms of international public transport, such as international railway trains and buses, of such limited quantities of Schedule II, III or IV substances as may be required for first aid or in emergency situations during their movement is not considered export, import or transit. through a country in the context of this Convention. 2. The country of registration shall take appropriate precautions to prevent the substances referred to in paragraph 1 from being misused or leaked for illegal purposes. The Commission, in consultation with relevant international organizations, recommends such precautions. 3. Substances transported in accordance with paragraph 1 on ships, aircraft or other types of international public transport, such as international railway trains and buses, are subject to the laws, regulations, permits and licenses of the country of registration, without prejudice to any rights of the competent local authorities to carry out inspections, inspections and other control measures. on these vehicles. The use of such substances in an emergency is not considered a violation of the provisions of paragraph 1 of article 9.

Article 15. Inspection The Parties should have a system of inspections of manufacturers, exporters and importers, wholesale and retail distributors of psychotropic substances, as well as medical and scientific research institutions using such substances. The Parties shall provide for various inspections of the relevant premises, stocks and registration records, which shall be carried out as often as they deem necessary.

Article 16. Reports submitted by the Parties 1. The Parties shall submit to the Secretary-General such information as the Commission may request from them as necessary for the performance of its functions, and in particular annual reports on the application of this Convention in their territories, including information on: (a) Significant changes in their laws and regulations concerning psychotropic substances; and (b) significant changes regarding the abuse of psychotropic substances and illicit trafficking in their territories. 2. The Parties shall also inform the Secretary-General of the names and addresses of the governmental authorities referred to in subparagraph (i) of Article 7, in article 12 and in paragraph 3 of Article 13. Such information shall be made available by the Secretary-General to all Parties. 3. The Parties shall send a communication to the Secretary-General as soon as possible after the incident in respect of any case of illicit trafficking or withdrawal from illicit trafficking that they consider important in view of: a) identified new trends; b) the quantities in question; (c) Information shedding light on the sources from which these substances are obtained; (d) Methods used by persons engaged in illicit trafficking. Copies of such a communication shall be sent in accordance with subparagraph (b) of article 21.4. The Parties shall submit annual statistical reports to the Committee on the forms established by the Committee.: (a) For each substance included in Schedules I and II, the quantities of such substance manufactured, exported to each country or area and imported from each country or area, as well as the stocks of such substance held by the manufacturers; (b) For each substance included in Schedules III and IV, the quantities of such manufactured substance, as well as the total quantities of such exported and imported substances; (c) For each substance included in Schedules II and III, the quantities of such substance used in the manufacture of preparations withdrawn fromand (d) for each substance other than those included in Schedule I, the quantities of the substance used for industrial purposes in accordance with subparagraph (b) of Article 4. The quantities of manufactured substances referred to in sub-paragraphs (a) and (b) of this paragraph do not include the quantity of manufactured preparations. 5. The Party shall provide, at the request of the Committee, additional statistical information relevant to future periods on the quantities of any of the substances included in Schedules III and IV exported to each country or area and imported from each country or area. That Party may request that the Committee treat both its request for information and the information provided in accordance with this paragraph as confidential. 6. The Parties shall provide the information referred to in paragraphs 1 and 4 of this Article in the manner and within such time limits as may be requested by the Commission or the Committee.

Article 17. Functions of the Commission 1. The Commission may consider all matters relating to the achievement of the objectives of this Convention and the implementation of its provisions, and may make recommendations on such matters. 2. The decisions of the Commission provided for in articles 2 and 3 shall be taken by a two-thirds majority vote of the Commission members.

Article 18. Reports of the Committee 1. The Committee shall prepare annual reports on its work, containing an analysis of the statistical information available to it and, where appropriate, a summary of explanations, if any, provided by or required from Governments, together with any observations and recommendations that the Committee may wish to make. The Committee may prepare such additional reports as it deems necessary. These reports are submitted to the Council through the Commission, which may make such comments as it deems appropriate. 2. The Committee's reports are sent to the Parties and then published by the Secretary-General. The Parties allow unlimited distribution of these reports.

Article 19. Measures taken by the Committee to ensure compliance with the provisions of the Convention 1. a) If, as a result of the Committee's examination of information provided to it by Governments or information sent by the organs of the Organization The Committee has reason to believe that the achievement of the objectives of this Convention is seriously threatened by the failure of a country or an area to comply with the provisions of this Convention. Under the Convention, the Committee has the right to seek clarification from the Government of that country or area. While maintaining the right of the Committee to draw the attention of the Parties, the Council and the Commission to the issue referred to in subparagraph (c) of this article, it shall treat the request for information or Government clarification in accordance with this subparagraph as confidential. (b) Having taken measures in accordance with subparagraph (a) of this article, the Committee, if it is satisfied that it is necessary to do so, may call upon the Government concerned to take such corrective measures as are deemed necessary in the circumstances to comply with the provisions of this Convention. (c) If the Committee considers that the Government concerned did not provide satisfactory explanations when requested to do so under subparagraph (a) of this article, or did not take any corrective measures that it was requested to take under subparagraph (b) of this article, it may draw the attention of the Parties, the Council and the Commission to this matter.. 2. The Committee, drawing the attention of the Parties, the Council and the Commission to any matter in accordance with subparagraph (c) of paragraph 1 of this article, may, if it is satisfied that this is necessary, recommend that the Parties stop exporting, importing or both exporting and importing certain psychotropic substances from or to the relevant country or area. to the country or area concerned, either for a specified period of time, or until the Committee is satisfied that the situation in that country or area is satisfactory. The relevant State may raise the issue with the Council. 3. The Committee shall have the right to publish a report on any matter considered in accordance with the provisions of this article and to forward this report to the Council, which shall circulate it to all Parties. If the Committee includes in its published report a decision taken pursuant to this article or any information related to such a decision, it should also include in that report the views of the Government concerned, if requested to do so. 4. If in any case the decision of the Committee published in accordance with this article was not adopted unanimously, the minority point of view is stated. 5. Any State is invited to send a representative to a meeting of the Committee at which a matter directly concerning that State is being considered in accordance with this article. 6. Decisions of the Committee pursuant to this article shall be taken by a two-thirds majority vote of all members of the Committee. 7. The provisions of the above paragraphs shall also apply in cases where the Committee has reason to believe that the achievement of the objectives of this The Convention is seriously threatened as a result of any decision taken by a Party in accordance with paragraph 7 of Article 2.

Article 20. Measures against the abuse of psychotropic substances 1. The Parties shall take all possible measures aimed at preventing the abuse of psychotropic substances and at early detection, treatment, upbringing, restoration of working capacity, return to society of the persons concerned and monitoring them after the end of their treatment, as well as coordinate their efforts to achieve these goals. 2. The Parties shall promote, as far as possible, the training of personnel for the treatment, rehabilitation and return to society of persons who abuse psychotropic substances, as well as for monitoring them after their treatment. 3. The Parties shall promote the familiarization of persons who need it for work with the problems of psychotropic substance abuse and its prevention, and also contribute to the familiarization of the population with these problems if there is a danger that the abuse of these substances will become widespread.

Article 21. Measures against illicit trafficking With due regard to their constitutional, legal and administrative systems, the Parties: (a) Take domestic measures to coordinate preventive and repressive measures against illicit trafficking; to this end, they may usefully appoint an appropriate body responsible for such coordination; (b) Assist each other in conducting a campaign to combat illicit trafficking in psychotropic substances and, in particular, send them immediately through diplomatic channels or through competent authorities designated by For this purpose, the Parties shall provide other Parties directly concerned with a copy of any communication they have sent to the Secretary-General in accordance with Article 16 in connection with the discovery of a case of illicit trafficking or in connection with the seizure; (c) Cooperate closely with each other and with the competent international organizations of which they are members in order to conduct a coordinated campaign against illicit trafficking; (d) ensure the expeditious implementation of international cooperation between the relevant authorities; and (e) ensure that, in cases where prosecution requires the transfer of legal documents to In accordance with the international procedure, such transfer was carried out promptly to those bodies that will be appointed by the Parties.; this provision is without prejudice to the right of any The parties shall require that legal documents be sent to it through diplomatic channels.

Article 22. Provisions on penalties 1. (a) Subject to constitutional restrictions, each Party shall consider as a punishable offense, in cases where it is committed intentionally, any act contrary to any law or regulation adopted in fulfillment of its obligations under this Convention. The Convention, and ensures that serious offences are punishable appropriately, in particular by imprisonment or other form of deprivation of liberty.; (b) Notwithstanding the provisions of the preceding subparagraph of this article, in cases where persons abusing psychotropic substances commit such offences, the Parties may provide, either as a substitute for conviction or punishment, or in addition to punishment, that such persons be subject to measures in accordance with paragraph 1 of article 20 aimed at their treatment, education, supervision of them after graduation or treatment, restoration of their ability to work and their return to society. 2. Subject to the constitutional restrictions of a Party, its legal system and domestic law, (a) (i) if a number of interrelated acts constituting offences under paragraph 1 have been committed in different countries, each of these acts shall be treated as a separate offence; (ii) Intentional participation in the commission, conspiracy to commit and attempts to commit any of such offences, as well as preparatory actions and financial transactions in connection with the offences referred to in this article, are punishable offences as provided for in paragraph 1; (iii) sentences of foreign courts for such offences are taken into account for the purposes of establishing recidivism.; and (iv) The serious offences mentioned above, committed either by nationals of the country concerned or by foreigners, are prosecuted by the Party in whose territory the offence was committed or by the Party in whose territory the offender was found, if extradition is prohibited under the laws of the Party to which the request is addressed., and if this offender has not yet been prosecuted and the verdict in his case has not yet been passed. (b) It is desirable that the offences referred to in paragraph 1 and in subparagraph (a) (ii) of paragraph 2 be included among the offences for which the perpetrators are extraditable in any extradition treaty that is concluded or may subsequently be concluded between any Parties, and recognized in relations between any Parties that are not extradition is conditional on the existence of a contract or reciprocity, as crimes for which the perpetrators are subject to extradition, provided that it is resolved in accordance with the law of the Party to whom the extradition request is addressed., and that this Party has the right to refuse to make an arrest or allow extradition in cases where its competent authorities consider that the offense is not serious enough. 3. Any psychotropic substance or other substance, as well as any equipment used or intended for the commission of any of the offences referred to in paragraphs 1 and 2 of this article, shall be subject to seizure and confiscation. 4. In matters of jurisdiction, the provisions of the relevant domestic law The Parties shall prevail over the provisions of this article. 5. Nothing contained in this article affects the principle that the offences covered by it are defined, prosecuted and punished in accordance with the domestic law of a Party.

Article 23. The application of stricter control measures than those provided for in this Convention A Party may take stricter or more severe control measures than those provided for in this Convention if, in its opinion, such measures are desirable or necessary to protect public health and well-being.

Article 24. Expenses of international bodies in connection with the implementation of the provisions of this Convention The expenses of the Commission and the Committee in connection with the performance of their functions under this Convention shall be borne by the United Nations in a manner to be determined by the General Assembly. Parties that are not Members of the United Nations shall contribute to these costs such amounts as the General Assembly considers fair and which it determines from time to time in consultation with the Governments of those Parties.

Article 25. Procedure for admission, signature, ratification and accession 1. States Members of the United Nations, States that are not Members of the United Nations but are members of a specialized agency of the United Nations or the International Atomic Energy Agency or parties to the Statute The International Court of Justice, or any other State invited by the Council, may become Parties to this Convention.: a) by signing it; or (b) by ratification after signing it, subject to ratification; or (c) by acceding to it. 2. The Convention is open for signature until January 1, 1972 inclusive. After that date, it will be open for accession. 3. The instruments of ratification or accession shall be deposited. To the Secretary General.

Article 26. Entry into force 1. The Convention shall enter into force on the ninetieth day after the forty States referred to in paragraph 1 of article 25 have signed it without reservation of ratification or deposited their instruments of ratification or accession. 2. In respect of any other State which signs this Convention without reservation of ratification or deposits an instrument of ratification or accession after the last signature or the last deposit referred to in the preceding paragraph, the Convention shall enter into force on the ninetieth day after the signature or deposit of the instrument of ratification or accession.

Article 27. Territorial application This Convention applies to all non-metropolitan territories for whose international relations a Party is responsible, except in cases where the prior consent of such territory is required by the constitution of that Party or the Territory concerned, or where custom requires it. In this case, the Party concerned should seek to obtain the necessary consent of the Territory concerned as soon as possible and, upon receipt of such consent, notify the Secretary General thereof. The secretary. This Convention shall apply to the territory or territories indicated in such notification from the date of its receipt by the Secretary-General. In cases where the prior consent of a territory outside the metropolitan area is not required, the interested Party, at the time of signature, ratification or accession, indicates the territory outside the metropolitan area or territories to which this Convention applies.

Article 28. Areas for the purposes of this Convention 1. Any Party may notify the Secretary-General that, for the purposes of this Convention, its territory is divided into two or more areas or that two or more of its areas are being combined into one area. 2. Two or more Parties may notify the Secretary General that, as a result of the conclusion of a customs union between them, these Parties constitute one area for the purposes of this Convention. 3. Any notification made pursuant to paragraphs 1 and 2 of this article shall enter into force on 1 January of the year following the year in which the notification was made.

Article 29. Denunciation 1. Upon the expiration of two years from the date of entry into force of this Convention, any Party may, on its own behalf or on behalf of the Territory for which it bears international responsibility and which has withdrawn its consent in accordance with article 27, denounce this Convention by a written act deposited with the Secretary-General. 2. The denunciation, if notified by the Secretary-General in any year on or before 1 July, shall take effect on 1 January of the following year, and if such notification is received after 1 July, the denunciation shall take effect as if it had been received on or before 1 July of the following year. 3. This Convention shall terminate if, as a result of denunciations carried out in accordance with paragraphs 1 and 2, the conditions necessary for its entry into force in accordance with paragraph 1 of article 26 cease to exist.

Article 30. Amendments 1. Any Party may propose an amendment to this Convention. The text of any such amendment and the reasons for it shall be communicated to the Secretary-General, who shall communicate them to the Parties and the Council. The Council may decide that: (a) Either a conference should be convened in accordance with paragraph 4 of Article 62 of the Charter of the United Nations to consider the proposed amendment, or (b) The Parties should be asked if they accept the proposed amendment and asked to submit any comments on the proposal to the Council. 2. If the proposed amendment sent out on the basis of subparagraph (b) of paragraph 1 of this Article has not been rejected by any Party within eighteen months after its dispatch, it shall enter into force thereafter. If the proposed amendment is rejected by a Party, the Council may decide, in the light of comments received from the Parties, whether a conference should be convened to consider the amendment.

Article 31. Disputes 1. In the event of any dispute between two or more Parties concerning the interpretation or application of this Convention. According to the Convention, these Parties consult with each other in order to resolve the dispute through negotiations, investigation, mediation, conciliation, arbitration, recourse to regional judicial authorities or other peaceful means of their own choice. 2. Any dispute of this kind that cannot be resolved in the manner specified in paragraph 1 shall, at the request of any of the Parties to the dispute, be referred to the International Court of Justice for resolution.

Article 32. Reservations 1. Only reservations made in accordance with paragraphs 2, 3 and 4 of this article are permitted. 2. At the time of signature, ratification or accession, any State may make reservations with respect to the following provisions of this Convention: (a) Paragraphs 1 and 2 of Article 19; (b) Article 27; and (c) Article 31. 3. A State wishing to become a Party but in order to make reservations other than those made in accordance with paragraphs 2 and 4 of this article may notify the Secretary-General of such intention. If, after twelve months from the date of notification by the Secretary-General of the reservation in question, the reservation has not been rejected by one third of the States that have signed, ratified or acceded to this Convention without reservation of ratification before the end of that period, it shall be considered permissible, provided, however, that the States that objected to the reservation are not required to to assume, in respect of the reserving State, any legal obligation under this Convention that is affected by the reservation. 4. A State in whose territory wild plants containing psychotropic substances from among the substances included in Schedule I are found and traditionally used by some small, clearly defined groups of the population in magical or religious rituals may, at the time of signature, ratification or accession, make reservations regarding these plants with respect to the provisions of Article 7 of this Convention. Conventions, with the exception of provisions relating to international trade. 5. A State that has made reservations may, by written notification addressed to the Secretary-General, withdraw all or part of its reservations at any time.

Article 33. Notifications The Secretary-General shall notify all States referred to in paragraph 1 of article 25 of: (a) signatures, ratifications and accessions in accordance with article 25; (b) the date of entry into force of this Convention in accordance with article 26; (c) denunciations in accordance with article 29; and (d) declarations and notifications in accordance with articles 27, 28, 30 and 32.

In witness whereof, the undersigned, being duly authorized thereto,

have been authorized and have signed this Convention on behalf of their Governments. Done at Vienna on the twenty-first of February, one thousand nine hundred and seventy-one, in a single copy, of which the Chinese, English, French, Russian and Spanish texts are equally authentic. Real The Convention will be deposited with the Secretary General of the Organization. Of the United Nations, which shall transmit certified copies of this To all Members of the United Nations and other States referred to in paragraph 1 of Article 25 of the Convention. Revised Lists, including all amendments made by the Commission on Narcotic Drugs, as of July 1, 1993 List of substances included in the lists List of narcotic drugs included in Schedule I ----------------------------------------------------- International Other unregistered Chemical name unregistered or unscientific names ----------------------------------------------------------------- 1. BROLAMPHETAMINE DOB (+-)-4-bromo-2, 5-dime-toxy-alpha-methylphenetylamine 2. CATHINONE (-)-(S)-2-aminopropiophenone 3. DET (DET) 3-[2-(diethylamino) ethyl] indole 4. DMA (DMA) (+-)-2, 5-dimethoxy-alpha-methylphenethylamine 5. DMHP (DMHP) 3-(1,2-dimethylheptyl)- 7, 8, 9, 10-tetrahydro- 6, 6, 9-trimethyl-6H- dibenzo [b, d] - pyran-1-ol 6. DMT (DMT) 3-[2-(dimethylamino)ethyl] indole 7. DOET (DOET) (+-)-4-ethyl-2,5-dime-toxy-alpha-phenethylamine 8. N-ETHYL- MDE (MDE) (+-)-N-ethyl-alpha-methyl-TENAMPHETAMINE N-ETHYL-MDA 3, 4-(methylenedioxy) phe- (N-ETHYL-MDA) netylamine 9. ETHYCYCLIDINE PCG (PCE) N-ethyl-1-phenylcyclohexylamine 10. N-HYDROXY- N-ONE MDA (+-)-N-[alpha-methyl-3, TENAMPHETAMINE (N-ONE MDA) 4-(methylenedioxy) phene- N-HYDROXY-MDA thyl] hydroxylamine (N-HYDROXY-MDA) 11. (+-)-LYSERGIC ACID LSD, LSD-25 9, 10-didehydro-N, N-di- (LSD, LSD-25) ethyl-6 methylergoline-8 betta-lysergic acid 12. MDMA (MDMA) (+-)-N, alpha-dimethyl-3, 4-methylenedioxy) phenethylamine 13. mescaline 3, 4, 5-trimethoxyphenethylamine 14. 4-METHYLAMINOREX (+-)-cis-2-amino-4-methyl-5-phenyl-2-oxazoline (+-)-cis-4, 5-dihydro-4-methyl-5phenyl-2-oxazole- min 15. MMDA (MMDA) 2-methoxy- -methyl-4,5- (methylenedioxy) phenethyl-amine 16. parahexyl 3-hexyl-7, 8, 9, 10- tetrahydro-6, 6, 9-tri-methyl-6H-dibenzo [b, d] pyram-1-ol 17. PMA (PMA) 2-methoxy-methylpheno-thylamine 18. psilotium, psilotsin 3-[2-(dimethylamino) ethyl] indole-4-ol 19. PSILOCYBIN 3-[2-(dimethylamino) ethyl] indole-4-yl dihydrophosphate 20. ROLICYCLIDINE FTP (RNR, RSRU) 1-(1-phenylcyclohexyl) Pyrrolidine 21. STP, HOUSE 2-5-dimethoxy-alpha, (STR, DOM) 4-dimethylphenethylamine 22. TENAMPHETAMINE MDA (MDA) alpha-methyl-3, 5-(methylenedioxy) phenethyl-amine 23. TENOCYCLIDINE TP (TSR) 1-[-(2-thionyl) cyclohexyl] piperidine 24. tetrahydrocannabinol, the following isomers and their stereochemical variants: 7, 8, 9, 10-tetrahydro- 6, 6, 9-trimethyl-3-pentethyl-6H-dibenzo [b, d] piran-1-ol (9R, 10aR)-8, 9, 10, 10a-tetrahydro-6, 6, 9-trimethyl-3-pontil-6H-di- benzo [b, d] piran-1-ol (6aR, 9R, 10aR)-6a, 9, 10, 10a-tetrahydro-6, 6, 9-trimethyl-3-pentyl-6H- dibenzo [b, d] piran-1-ol (6aR, 10aR)-6a, 7, 10, 10a-tetrahydro-6, 6, 9-trimethyl-3-pentyl-6H- dibenzo [b, d] piran-1- ol 6a, 7, 8, 9- tetrahydro-6, 6, 9-trimethyl-3-pentyl-6H-dibenzo [b, d] piran-1-ol (6aR, 10aR)-6a, 7, 8, 9, 10, 10a-hexahydro-6, 6- dimethyl-9-methylene-3-pentyl-6H- dibenzo [b, d] piran-1- ol 25. TMA (TMA) (+-)-3, 4, 5- Trimethoxy-alpha-Methylphenethylamine Salts of substances listed in this In the List, in all cases where the existence of such salts is possible. List of substances included in Schedule II ---------------------------------------- International Other unregistered Chemical name unregistered or unscientific names Names ----------------------------------------------------------------- 1 . AMPHETAMINE amphetamine (+-)-alpha-methylphenetil-amine 2. DEXAMPHETAMINE dexamphetamine (+)-alpha-methylphenetil-amine 3. DRONABINOL (-)-trans-delta- (6aR, 10aR)-6a, 7, 8, 9-tetrahydro-canna- 10a-tetrahydro-6, 6, 9-binol trimethyl-3-pentyl-6H-di-benzo [b, d] piran-1-ol 4. PHENETHYLLINE 7-[2-[(alpha-methylphenethyl) amino] ethyl] theophyllin 5. LEVAMPHETAMINE levamphetamine (-)-(R)-alpha-methylphenethylamine 6. Levometamphetamine (-)-N, alpha-dimethylphenethylamine 7. MECLOQUALONE 3-(o-chlorophenyl)-2-methyl 4(3H)-quinazolinone 8. METHAMPHETAMINE methamphetamine (+-)-(S)-N, alpha-dimethylphenethylamine 9. RACEMATE racemate (+-)-(S)-N, alpha dime- METHAMPHETAMINE methamphetamine tilphenethylamine 10. METHAQUALONE 2-methyl-3-o-tolyl- 4(3H)-quinazolinone 11. METHYLPHENIDATE Methyl-alpha-phenyl-2-pyperidine-cetate 12. PHENCYCLIDINE FCP (PCP) 1-(1-phenylcyclohexyl) piperidine 13. PHENMETRAZINE 3-methyl-2-phenylmorpholine 14. SECOBARBITAL 5-allyl-5-(1-methylbutyl) barbituric acid Salts of the substances listed in this List, in all cases where the existence of such salts is possible. List of substances included in Schedule III ----------------------------------------- International Other unregistered Chemical name unregistered or unscientific name common names ----------------------------------------------------------------- 1 . AMOBARBITAL 5-ethyl-5-isopentylbarbituric acid 2.

2-oh 14. CLOXAZOLAM 10-chloro-11b-(o-chlorophenyl)-2, 3, 7, 11b- tetrahydrooxazolo- [3, 2-d] [1,4] benzo-diazepine-6(5H)-one 15. DELORAZEPAM 7-chloro-5-(o-chloro-phenyl)-1, 3-dihydro-2H- 1, 4,-benzodiazepine-2-oh 16. DIAZEPAM 7-chloro-1-, 3-dihydro-1-methyl-5-phenyl-2H-1, 4-benzodiazepine-2-one 17. ESTAZOLAM 8-chloro-6-phenyl-4H-b-triazolo [4,3-a] [1,4] benzodiazepine 18. ETHCHLOROVINOL 1-chloro-3-ethyl-1-pentene- 4-in-3-ol 19. ETHINAMATE 1-ethinylcyclohexanol carbamate 20. ETHYL LOFLAZEPATE ethyl 7-chloro-5-(o-fluorophenyl)-2, 3-dihydro-2-oxo-1H-1, 4-benzo-diazepine-3-carboxylate 21. ETHYLAMPHETAMINE N-ethylamphetamine N-ethyl-alpha-methylphene- thylamine 22. PHENKAMPHAMINE N-ethyl-3-phenyl-2-norboranamine 23. PHENPROPOREX (+-)-3-[(alpha-methylphenethyl) amino] propionitryl 24. FLUDIAZEPAM 7-chloro-5-(o-fluoro-phenyl)-1, 3-dihydro-1- methyl-2H-1,4-benzodiazepine-2-oh 25. FLUNITRAZEPAM 5-(o-fluorophenyl)- 1,3-dihydro-1-methyl-7- nitro-2H-1,4-benzodiazepine-2-one 26. FLURAZEPAM 7-chloro-1-[2-(diethyl-no)-ethyl]-5-(o-fluorophenyl)-1, 3-dihydro-2H-1,4-benzodiazepine- 2-oh 27. CHALAZEPAM 7-chloro-1, 3-dihydro-5-phenyl-1-(2, 2, 2- triphloroethyl)-2H-1,4-ben-zodiazepine-2-oh 28. HALOXAZOLAM 10-bromo-11b-(o-flu-orophenyl) 2,3,7,11b- tetrahydrooxazolo [3,2-d] [1,4] benzo-diazepine-6(5H)-He's 29. KETAZOLAM 11-chloro-8, 12b-dihydro- 2, 8-dimethyl-12b-phenyl- 4H-[1,3] oxazino [3,2-d] [1,4] benzo-diazepine-4,7 (6H)-dione 30. LEFETAMINE SPA (-)-N, N-dimethyl-1,2- diphenyl-ethylamine 31. LOPRAZOLAM 6-(o-chlorophenyl)- 2,4-dihydro-2[(4-methyl-1-piperazinyl) methylene]- 8-nitro-1H-imidazo [1,2-a] [1,4] benzo-diazepine-1-one 32. LORAZEPAM 7-chloro-5-(o-chloro-phenyl) 1,3-dihydro-3-hydroxy-2H-1,4 benzo-diazepine-2-one 33. LORMETAZEPAM 7-chloro-5-(o-chloro-phenyl)-1,3-dihydro-3- hydroxy-1-methyl-2H-1,4-benzodiazepine-2-oh 34. MAZINDOL 5-(p-chlorophenyl)-2, 5-dihydro-3H-imidazo [2,1-a] isoindol-5-ol 35. MEDAZEPAM 7-chloro-2,3-dihydro-1-methyl-5-phenyl-1H-1,4-benzodiazepine 36. MEFENOREX N-(3-chloropropyl)-alpha-methyl-phenethylamine 37. MEPROBAMATE 2-methyl-2-protil-1, 3-propanediol dicarbamate 38. METHYLPHENOBARBITAL 5-ethyl-1-methyl-5-phenyl-barbituric acid 39. METHYPRILONE 3, 3-diethyl-5-methyl-2, 4-piperidine-dione 40. MIDAZOLAM 8-chloro-6-(o-fluro-phenyl)-1-methyl-4H-imidazo [1,5-a] [1,4] benzodiazepine 41. NIMETHAZEPAM 1,3-dihydro-1-methyl-7-nitro-5-phenyl-2H-1, 4- benzodiazepine 2-oh 42. NITRAZEPAM 1, 3-dihydro-7-nitro-5-phenyl-2H-1, 4-benzodiazepine-2-one 43. NORDAZEPAM 7-chloro-1, 3-dihydro-5-phenyl-2H-1, 4-benzodiazepine-2-one 44. OXAZEPAM 7-chloro-1,3-dihydro-3-hydroxy-5-phenyl-2H-1,4-benzodiazepine-2-oh 45. OXAZOLAM 10-chloro-2, 3, 7, 11b- tetrahydro-2-methyl-11b- phenyloxazolo [3, 2-d] [1, 4] benzodiazepine- 6(5H)-oh 46. PEMOLINE 2-amino-5-phenyl-2-oxazoline-4-one 2-imino-5-phenyl-4-oxazolidinone 47. FENDIMETRAZINE (+)-(2S, 3S)-3, 4-dimethyl-2 phenylmorpholine 48. PHENOBARBITAL 5-ethyl-5-phenylbarbituric acid 49. PHENTERMINE alpha, alpha-dimethyl-phenethylamine 50. PINAZEPAM 7-chloro-1, 3-dihydro-5-phenyl-1 (2-propynyl)- 2H-1, 4-benzodiazepine- 2-oh 51. PIPRADROL alpha, alpha-diphenyl-2- piperidine methanol 52. PRAZEPAM 7-chloro-1-(cyclopropyl-methyl)-1, 3-dihydro-5-phenyl-2H-1, 4-benzodiazepine-2-one 53. PYROVALERON 4-methyl-2-(1-pyrodinyl) valerophenone 54. SECBUTABARBITAL 5-wt-butyl-5-ethylbarbituric acid 55. TEMAZEPAM 7-chloro-1,3-dihydro-3-hydroxy-1-methyl-5-phenyl-2H-1,4-benzodiazepine-2-one 56. TETRAZEPAM 7-chloro-5-(1-cyclohexene-1-methyl-2H-1,4-ben- zodiazepine-2-oh 57. TRIAZOLAM 8-chloro-6-(o-chloro-phenyl)-1-methyl-4H-b-triazolo [4,3-a] [1,4] benzodiazepine 58. VINYLBITAL 5-(1-methylbutyl)-5- vinylbarbituric acid Salts of the substances listed in this List, in all cases where the existence of such salts is possible.

President

Republic of Kazakhstan

Constitution Law Code Standard Decree Order Decision Resolution Lawyer Almaty Lawyer Legal service Legal advice Civil Criminal Administrative cases Disputes Defense Arbitration Law Company Kazakhstan Law Firm Court Cases